Deferred Tax Assets, Valuation Allowance of iTeos Therapeutics, Inc. from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
iTeos Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2019 to 31 Dec 2024.
  • iTeos Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $97,331,000, a 31% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

iTeos Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $97,331,000 +$22,933,000 +31% 31 Dec 2024 10-K 05 Mar 2025 2024 FY
Q4 2023 $74,398,000 +$28,977,000 +64% 31 Dec 2023 10-K 05 Mar 2025 2024 FY
Q4 2022 $45,421,000 +$18,774,000 +70% 31 Dec 2022 10-K 06 Mar 2024 2023 FY
Q4 2021 $26,647,000 -$5,382,000 -17% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q4 2020 $32,029,000 +$10,356,000 +48% 31 Dec 2020 10-K 23 Mar 2022 2021 FY
Q4 2019 $21,673,000 31 Dec 2019 10-K 24 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.